Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-3

  1. 931 Posts.
    lightbulb Created with Sketch. 566
    That's the same part that stuck out to me.....things are looking really good !!!

    Wouldn't be surprised if Jazz Pharma ends up buying the rights to this drug if it proves to be a better formulation that epidiolex.....Exciting to think about smile.png !!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $21.40M
Open High Low Value Volume
3.4¢ 3.5¢ 3.1¢ $221.0K 6.502M

Buyers (Bids)

No. Vol. Price($)
1 400000 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 392668 1
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.